| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |